The Venous Center

Filter Your Results




EINSTEIN DVT Trial Data Presented at ESC

August 31, 2010—Johnson & Johnson Pharmaceutical Research & Development, LLC (Raritan, NJ) announced that the data from the pivotal phase 3 EINSTEIN-DVT cl…

AngioDynamics Expands VenaCure EVLT System

August 30, 2010—AngioDynamics (Queensbury, NY) announced the launch of a new access kit for use with the company’s VenaCure endovenous laser treatment (EVLT) system’s Ne…

SIR Supports Research for Endovascular Treatments of Multiple Sclerosis

August 26, 2010—The Society of Interventional Radiology (SIR) has issued a position statement indicating its support for high-quality clinical research to determine the safe…

Rivaroxaban Meets Primary Endpoint in EINSTEIN-DVT Study

August 4, 2010—Bayer AG (Leverkusen, Germany) announced that in the treatment of deep vein thrombosis (DVT), a single-drug treatment approach with oral rivaroxaban met the p…

Meeting the Challenge

Suresh Vedantham, MD

July 2010—An update on the ATTRACT trial.

Chronic Cerebrospinal Venous Insufficiency

Salvatore J.A. Sclafani, MD
Commentary by Michael D. Dake, MD,
and Barry T. Katzen, MD

July 2010—A new paradigm and therapy for multiple sclerosis.

Management of Intraosseous AVMs

Wayne F. Yakes, MD

July 2010—Because bone vascular AVMs are rarely seen in day-to-day practice, clinicians should be aware of the steps for proper diagnosis and the available treatment options to improve patient outcomes.

A Dedicated IVC Filter Clinic

Jeet Minocha, MD; Robert K. Ryu, MD; Jennifer Karp, RN; and Robert J. Lewandowski, MD

July 2010—A clinic with this singular focus may improve the retrieval rates of optional IVC filters.



2017 Device Guide

This Device Guide offers a searchable, comprehensive listing of the available vascular interventional devices in the United States.


Contact Info

For advertising rates and opportunities, contact:
Craig McChesney

Stephen Hoerst

Charles Philip

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.